Health Care Equipment

Masimo Corp (NASDAQ: MASI) shares are trading lower after the company reported Q2 2023 preliminary results and revised 2023 outlook yesterday. Q2 2023: The company expects revenues of $453 million- $457 million range (consensus: $553.23 million). The healthcare revenue is expected to be $...

Wells Fargo initiated coverage on Masimo Corporation (NASDAQ: MASI) with an Equal Weight rating and a price target of $173. The analyst says it is optimistic about the Healthcare business and sees potential upside from new Consumer Health products in 2024 and beyond. Still, the...

Needham analyst Mike Matson reiterated a Buy rating on the shares of Masimo Corporation (NASDAQ: MASI), raising the price target to $207.00 from $192.00. The analyst believes that new product launches, market share gains, and new businesses such as hospital automation should...

The California State Teachers' Retirement System (CalSTRS) has joined Politan Capital Management to stop Masimo Corp's (NASDAQ: MASI) CEO from receiving more than $500 million if there are changes to the corporate governance, including its board of directors....

Raymond James upgraded Masimo Corporation (NASDAQ: MASI) from Market Perform To Outperform with a price target of $187 and says that no other company in its coverage offers as many paths to incremental value creation. The analyst writes that the stock setup seems...

MACOM Technology Solutions Holdings Inc (NASDAQ: MTSI) reported first-quarter FY23 revenue growth of 12.8% year-on-year to $180.1 million, beating the analyst consensus of $179.7 million. Adjusted gross margin expanded by 120 bps to 62.6%, while the adjusted operating margin decreased by...

The Nasdaq Composite dropped around 0.5% on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go...

Although US stocks closed higher on Tuesday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider...

U.S. stocks closed higher on Friday, with the Dow Jones gaining more than 800 points. Here is the list of some big stocks recording losses in the previous session. DaVita Inc. (NYSE: DVA) shares dipped 27.1% to close at $70.54 after the company reported worse-than-expected Q3 EPS and sales results...

Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) jumped 153.9% to close at $3.30 on Friday. Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) surged 61.4% to close at $0.92 after jumping 15% on Thursday. Nuvalent, Inc. (NASDAQ: NUVL) shares gained 60.6% to close at $35.34 after the company reported...

Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) surged 179% to $3.6301. Nuvalent, Inc. (NASDAQ: NUVL) shares jumped 62% to $35.60 after the company reported preliminary Phase 1 clinical data from the ARROS-1 trial that support the best-in-class potential of NVL-520 for patients with ROS1-positive...

Credit Suisse cut FedEx Corporation (NYSE: FDX) price target from $246 to $236. FedEx shares fell 1.9% to $151.56 in pre-market trading. Deutsche Bank cut FactSet Research Systems Inc. (NYSE: FDS) price target from $507 to $483. FactSet Research shares fell 8.3% to close at $394.75 on Thursday...

RBC Capital cut the price target for Nuvei Corporation (NASDAQ: NVEI) from $80 to $60. Nuvei shares fell 21.5% to close at $33.03 on Tuesday. Piper Sandler increased the price target on Masimo Corporation (NASDAQ: MASI) from $130 to $135. Masimo shares fell 4.2% to close at $148.17 on Tuesday....

Masimo Corp's (NASDAQ: MASI) Q2 revenue increased 85.3% Y/Y to $565.3 million, beating the consensus of $540.56 million.  Healthcare revenue was $357.0 million, +17% on reported basis and 19.0% on constant currency. Non-healthcare revenue was $208.3 million. Excluding...